Imedisync
1 known investors
iMediSync develops EEG-based medical devices and AI software, including dry-electrode brainwave headsets, a PBM (photobiomodulation) wearable, and analytics software for early screening of mild cognitive impairment and stress/emotion monitoring. Its products carry Korean MFDS approvals and US FDA clearances (including Class II).